Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Gulick · SciRah

Researcher profile · Semantic Scholar

R. Gulick

Share profile

R. Gulick — researcher profile on SciRah

h-index: 59
Works: 262
Citations: 19K

Most-cited papers

Clinical Characteristics of Covid-19 in New York City
P. Goyal, Justin J. Choi, Laura C. Pinheiro, E. Schenck +17 more
2020New England Journal of Medicine2,004 citations Open access
Semantic Scholar
3BNC117 a Broadly Neutralizing Antibody Suppresses Viremia in HIV-1-Infected Humans
M. Caskey, F. Klein, J. C. C. Lorenzi, M. Seaman +21 more
2015Nature726 citations Open access
Semantic Scholar
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
R. Landovitz, D. Donnell, M. Clement, B. Hanscom +61 more
2021New England Journal of Medicine699 citations Open access
Semantic Scholar
Combination therapy with anti-HIV-1 antibodies maintains viral suppression
Pilar Mendoza, H. Gruell, Lilian Nogueira, Joy A. Pai +32 more
2018Nature494 citations Open access
Semantic Scholar
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals
M. Caskey, T. Schoofs, H. Gruell, A. Settler +33 more
2017Nature Medicine474 citations Open access
Semantic Scholar
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
J. Scheid, J. Horwitz, Y. Bar-On, Edward F. Kreider +29 more
2016Nature469 citations Open access
Semantic Scholar
Safety and anti-viral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Y. Bar-On, H. Gruell, T. Schoofs, Joy A. Pai +29 more
2018Nature Medicine244 citations Open access
Semantic Scholar
Association between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk of Suicidal Ideation, Attempted, or Completed Suicide
K. Mollan, M. Smurzynski, J. Eron, E. Daar +7 more
2014Annals of Internal Medicine198 citations Open access
Semantic Scholar
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
G. Namazi, J. Fajnzylber, E. Aga, R. Bosch +28 more
2018Journal of Infectious Diseases197 citations Open access
Semantic Scholar
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants
E. Holzinger, Benjamin J. Grady, M. Ritchie, H. Ribaudo +8 more
2012Pharmacogenetics & Genomics144 citations Open access
Semantic Scholar
Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings
Thomas B. Campbell, L. Smeaton, N. Kumarasamy, T. Flanigan +154 more
2012PLoS Medicine131 citations Open access
Semantic Scholar
Long-Acting HIV Drugs for Treatment and Prevention.
R. Gulick, C. Flexner
2019Annual Review of Medicine105 citations Open access
Semantic Scholar
Relationship between latent and rebound viruses in a clinical trial of anti–HIV-1 antibody 3BNC117
Yehuda Z. Cohen, Julio C. C. Lorenzi, Lisa Krassnig, John P. Barton +17 more
2018Journal of Experimental Medicine105 citations Open access
Semantic Scholar
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL
Babafemi O. Taiwo, Lu Zheng, A. Stefanescu, A. Nyaku +10 more
2018Clinical Infectious Diseases87 citations Open access
Semantic Scholar
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.
T. Wilkin, C. Lalama, J. McKinnon, R. Gandhi +8 more
2012Journal of Infectious Diseases81 citations Open access
Semantic Scholar
Obesity and COVID-19 in New York City: A Retrospective Cohort Study
P. Goyal, J. Ringel, Mangala Rajan, Justin J. Choi +18 more
2020Annals of Internal Medicine78 citations Open access
Semantic Scholar
HIV treatment and prevention 2019: current standards of care.
N. Phanuphak, R. Gulick
2019Current Opinion in HIV and AIDS75 citations
Semantic Scholar
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.
Michael P. Girouard, Paul E. Sax, R. Parker, Babafemi O. Taiwo +5 more
2016Clinical Infectious Diseases66 citations Open access
Semantic Scholar
COVID-19 in Hospitalized Adults Living with HIV
K. Stoeckle, Carrie D. Johnston, D. Jannat-Khah, S. C. Williams +5 more
2020Open Forum Infectious Diseases59 citations Open access
Semantic Scholar
Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in High-Income Countries.
S. Cooper, J. Rosenblatt, R. Gulick
2022Clinical Infectious Diseases55 citations Open access
Semantic Scholar
5-year Safety Evaluation of Maraviroc in HIV-1-Infected, Treatment-Experienced Patients
R. Gulick, G. Fätkenheuer, R. Burnside, W. Hardy +5 more
2014Journal of Acquired Immune Deficiency Syndromes53 citations Open access
Semantic Scholar
Corrigendum: Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
M. Caskey, F. Klein, J. C. C. Lorenzi, M. Seaman +21 more
2016Nature51 citations Open access
Semantic Scholar
Efavirenz Pharmacogenetics and Weight Gain following Switch to Integrase Inhibitor-containing Regimens.
Michael A Leonard, Zinhle Cindi, Y. Bradford, Kassem Bourgi +16 more
2020Clinical Infectious Diseases50 citations Open access
Semantic Scholar
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.
H. Ribaudo, Kimberly Y. Smith, G. Robbins, C. Flexner +6 more
2013Clinical Infectious Diseases47 citations Open access
Semantic Scholar
Invasive Meningococcal Disease in Men Who Have Sex With Men
M. Simon, D. Weiss, R. Gulick
2013Annals of Internal Medicine44 citations Open access
Semantic Scholar
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group Protocols
C. Moore, A. Verma, S. Pendergrass, S. Verma +7 more
2014Open Forum Infectious Diseases37 citations Open access
Semantic Scholar
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants
K. Mollan, C. Tierney, J. Hellwege, J. Eron +11 more
2017Journal of Infectious Diseases34 citations Open access
Semantic Scholar
Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in Haiti
M. Charles, P. Leger, P. Sévère, Colette Guiteau +5 more
2012Journal of the International AIDS Society34 citations Open access
Semantic Scholar
NEXT GENERATION ORAL PrEP: BEYOND TENOFOVIR
B. Abraham, R. Gulick
2012Current Opinion in HIV and AIDS33 citations Open access
Semantic Scholar
Virologic and immunologic effects of adding maraviroc to suppressive ART in subjects with suboptimal CD4+ T-cell recovery
A. Cillo, Benedict B Hilldorfer, C. Lalama, J. McKinnon +9 more
2015AIDS (London)31 citations Open access
Semantic Scholar
Investigational Antiretroviral Drugs: What is Coming Down the Pipeline.
R. Gulick
2018Topics in antiviral medicine24 citations
Semantic Scholar
Blood component utilization in COVID‐19 patients in New York City: Transfusions do not follow the curve
R. DeSimone, Victoria Costa, K. Kane, Jorge L. Sepulveda +6 more
2020Transfusion23 citations Open access
Semantic Scholar
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease
M. Satlin, P. Goyal, Reed Magleby, Grace A Maldarelli +8 more
2020PLoS ONE23 citations Open access
Semantic Scholar
Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions
K. R. Amico, Catalina Ramirez, Margaret R. Caplan, Brooke E. E. Montgomery +11 more
2019Journal of the International AIDS Society23 citations Open access
Semantic Scholar
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353
A. Nyaku, Lu Zheng, R. Gulick, Maxine Olefsky +17 more
2019Journal of Antimicrobial Chemotherapy21 citations Open access
Semantic Scholar
Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.
Yu Zheng, M. Hughes, S. Lockman, C. Benson +9 more
2014Clinical Infectious Diseases19 citations Open access
Semantic Scholar
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank
S. Narayanasamy, Lesley H. Curtis, Adrian F. Hernandez, C. W. Woods +21 more
2023Clinical Infectious Diseases17 citations Open access
Semantic Scholar
Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19
Safia Kuriakose, Kanal Singh, A. Pau, E. Daar +6 more
2021Annals of Internal Medicine17 citations Open access
Semantic Scholar
Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection: Case Report and Review of the Literature
J. Humphrey, T. Walsh, R. Gulick
2016Open Forum Infectious Diseases17 citations Open access
Semantic Scholar
Novel clinical trial designs for the development of new antiretroviral agents
N. Mani, Jeffrey S. Murray, R. Gulick, F. Josephson +4 more
2012AIDS (London)15 citations Open access
Semantic Scholar
Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults
Bing-Lan Li, Y. Veturi, A. Verma, Y. Bradford +7 more
2020bioRxiv14 citations Open access
Semantic Scholar
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells
Dominique B. Figueroa, E. Madeen, J. Tillotson, P. Richardson +9 more
2018AIDS Research and Human Retroviruses14 citations Open access
Semantic Scholar
152 – Drugs for HIV Infection
B. Eckhardt, R. Gulick
201714 citations
Semantic Scholar
Genome-wide Association Study of Virologic Response with Efavirenz- or Abacavir-containing Regimens in AIDS Clinical Trials Group Protocols
David S Lehmann, H. Ribaudo, E. Daar, R. Gulick +5 more
2015Pharmacogenetics & Genomics14 citations Open access
Semantic Scholar
HIV treatment 2020: what will it look like?
R. Gulick
2014Journal of the International AIDS Society13 citations Open access
Semantic Scholar
The Pharmacokinetics, Pharmacodynamics, and Mucosal Responses to Maraviroc-Containing PrEP Regimens in Men who have Sex with Men
I. McGowan, T. Wilkin, R. Landovitz, Chun-yuan Wu +15 more
2019AIDS (London)12 citations Open access
Semantic Scholar
Higher Colorectal Tissue HIV Infectivity in Cisgender Women Compared to MSM Before and During Oral Pre-Exposure Prophylaxis
Rogers Sekabira, I. McGowan, K. Yuhas, R. Brand +16 more
2021AIDS (London)11 citations Open access
Semantic Scholar
Randomized Pilot Study of an Advanced Smart Pill Bottle as an Adherence Intervention in Patients with HIV on Antiretroviral Treatment
G. Ellsworth, L. Burke, Martin T. Wells, Satish Mishra +9 more
2021Journal of Acquired Immune Deficiency Syndromes11 citations Open access
Semantic Scholar
ART in HIV-positive persons with low pre-treatment viremia: results from the START trial
I. Sereti, R. Gulick, S. Krishnan, S. Migueles +5 more
2019Journal of Acquired Immune Deficiency Syndromes11 citations Open access
Semantic Scholar
Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy.
Jason Gillman, Patrick Janulis, R. Gulick, C. Wallis +5 more
2019Journal of Antimicrobial Chemotherapy10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Daar×11
Invite
E. Daar — researcher profile on SciRah
D. Haas×9
Invite
D. Haas — researcher profile on SciRah
M. Caskey×7
Invite
M. Caskey — researcher profile on SciRah
M. Seaman×7
Invite
M. Seaman — researcher profile on SciRah

I. Shimeliovich

×7

Invite

I. Shimeliovich — researcher profile on SciRah

M. Witmer-Pack×7

Invite

M. Witmer-Pack — researcher profile on SciRah

M. Nussenzweig×7

Invite

M. Nussenzweig — researcher profile on SciRah

Invite

F. Klein — researcher profile on SciRah

Lilian Nogueira×6

Invite

Lilian Nogueira — researcher profile on SciRah

G. Fätkenheuer×6

Invite

G. Fätkenheuer — researcher profile on SciRah

Invite

T. Wilkin — researcher profile on SciRah

Invite

C. Lehmann — researcher profile on SciRah